Login / Signup

Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study.

Yuedi HuJian LiuLing XinLei WanYajun QiYang LiYiming Chen
Published in: International journal of general medicine (2023)
HQC treatment can reduce the risk of readmission and significantly improve immune inflammatory indicators and SPP in patients with RA, with no risk of hepatorenal toxicity.
Keyphrases
  • oxidative stress
  • rheumatoid arthritis
  • disease activity
  • systemic lupus erythematosus
  • combination therapy
  • smoking cessation
  • oxide nanoparticles